Muscle Maker GrillOffering
The capital raising process completed on March 29th. Listing on the OTCQX is planned.
The capital raising process completed on March 29th. Listing on the OTCQX is planned.
Impervious to Rust and Corrosion Longer Service Life Broad Applications Unlike ... and corrosion. U.S. and Global Consumption of Steel Rebar RockRebar ® offers ... service life significantly reduces the need for maintenance and repairs. ...
our offering investment guide Thank you Thank you for downloading our ... our offering RETURN TO OFFERING PAGE the solution our business model who we are our investment philosophy our offering investment guide ...
our offering investment guide Thank you Thank you for downloading our ... our offering contact--> RETURN TO OFFERING the solution our business model who we are our investment philosophy our offering investment guide ...
our offering investment guide Thank you Thank you for contacting us. A member of our team will reach out to you shortly. RETURN TO OFFERING PAGE the solution our business model who we are our investment philosophy our offering ...
our offering investment guide Thank you Thank you for contacting us. A member of our team will reach out to you shortly. RETURN TO OFFERING the solution our business model who we are our investment philosophy our offering ...
If you move your company headquarters to the USA or Canada, and set up a "C" corporation an LLC or a Limited Partnership for it in the USA or Canada, then you can use RegA+ to raise capital. ...
for downloading our investment guide. Please visit the rest of our offering page or watch our video for more information. Explore the rest of our offering ... OPPORTUNITY WHO WE ARE MARKET STATISTICS RETURN TO OFFERING INVEST NOW Offering ...
In a Reg A+ offering non-accredited investors can invest up to 10% of their annual income/net worth per year, whichever is the larger amount, ... 2 Reg A+ offerings. Reg A+ investors are self-state their income and net ...
Develops targeted anti-cancer chemotherapy drugs with improved efficacy and lower side effects, currently in clinical trials at the Mayo Clinic.